The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of trofosfamide vs. adriamycin in elderly patients with previously untreated metastatic soft tissue sarcoma.
 
Joerg Thomas Hartmann
No Relationships to Disclose
 
Hans Georg Kopp
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Sanofi
Expert Testimony - MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Lilly; Novartis; Sanofi
 
Viktor Gruenwald
No Relationships to Disclose
 
Sophie Piperno-Neumann
No Relationships to Disclose
 
Annegret Kunitz
No Relationships to Disclose
 
Ralf Hofheinz
No Relationships to Disclose
 
Lothar Mueller
Honoraria - Ipsen; Roche Pharma AG
Speakers' Bureau - Ipsen
 
Michael Geissler
No Relationships to Disclose
 
Marius Horger
No Relationships to Disclose
 
Peter Fix
Consulting or Advisory Role - Amgen/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Roche Pharma AG
 
Jens Chemnitz
Consulting or Advisory Role - Ablynx; Amgen
Travel, Accommodations, Expenses - Amgen; PharmaMar
 
Robert Eckert
Travel, Accommodations, Expenses - Abbvie; Celgene; Gilead Sciences
 
Claus Hann von Weyhern
Consulting or Advisory Role - LabPMM
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Lilly; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Frank Mayer
No Relationships to Disclose